ALYMSYS
bevacizumab-maly
- Strength
- 100 mg/4mL
- Form
- Injection, Solution
- Class
- Vascular Endothelial Growth Factor Inhi…
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
bevacizumab-bvzr
Listed by Pfizer Laboratories Div Pfizer Inc
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Vascular Endothelial Growth Factor Inhibitor |
| Approval route | BLA — biologic licence |
| NDC code | 0069-0315 |
| FDA application | BLA761099 |
| RxNorm concept | 2268039 |
| Package sizes listed | 1 |
| Marketed since | January 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
bevacizumab-maly
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
bevacizumab-maly
Amneal Pharmaceuticals LLC
Not stocked by us — reference only
bevacizumab
Genentech, Inc.
Not stocked by us — reference only
bevacizumab
Genentech, Inc.
Not stocked by us — reference only
bevacizumab-nwgd
Biocon Biologics Inc.
Not stocked by us — reference only
bevacizumab-nwgd
Biocon Biologics Inc.
Not stocked by us — reference only
bevacizumab-vikg
Outlook Therapeutics, Inc.
Not stocked by us — reference only
bevacizumab-awwb
Amgen, Inc
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.